Table 5.
PIAS3 expression in MS patients compared with healthy subjects
| Control numbers | MS patient numbers | Expression ratio | ΔΔCT | SD | P-value | 95% highest density interval | ||
|---|---|---|---|---|---|---|---|---|
| Total | 52 | 48 | 0.8615 | −0.397 | −0.43 | 0.485 | −1.05 to 0.26 | |
| Male | 15 | 9 | 1.1217 | 0.217 | −0.86 | 0.646 | −0.95 to 1.47 | |
| Female | 37 | 39 | 0.7977 | −0.53 | −0.23 | 0.403 | −1.34 to 0.28 | |
| <30 | Male | 2 | 0 | – | – | – | – | – |
| Female | 8 | 9 | 0.6876 | −0.83 | −1.16 | 0.583 | −3.54 to 1.93 | |
| 30–40 | Male | 2 | 3 | 1.1799 | – | – | – | – |
| Female | 7 | 15 | 1.3370 | 0.393 | 0.44 | 0.422 | −1.3 to 2.1 | |
| >40 | Male | 11 | 6 | 1.1479 | 0.258 | 1.6 | 0.683 | −2.07 to 2.56 |
| Female | 22 | 15 | 0.6357 | −0.825 | −0.25 | 0.253 | −2.08 to 0.42 | |
Abbreviation: MS, multiple sclerosis.